Easy Street Investing

Latest Articles

The Secret to S’More Retirement

by Nilus Mattive |

Last week’s article on financial advice for children got a lot of great feedback, including a message from a reader who mentioned the famous Stanford marshmallow experiment.

I wrote about that topic a few years ago, but in case you missed it, here’s the basic idea …

Back in the late 1960s and early 1970s researchers took a group of kids (ages 4-6) and offered them each a single marshmallow to eat.

However, they also gave them another option — wait 15 minutes without eating the marshmallow and have a second one.

All told, …

[Read Post »]

Teva-Mylan Merger Could Create a Global Pharma Powerhouse

by Frank Curzio |

Three months ago, I told you why drug patent expiration is quickly becoming a $214 billion trend.

We zeroed in on Mylan (MYL), one of the largest generic drug-makers in the world. That’s because it is a big potential beneficiary.

As I explained, $214 billion in worldwide drug sales were coming off patent in the next six years (2015 to 2020).

Generic companies are allowed to make identical drugs (by law) once a patent expires.

And Mylan is one of the few companies positioned to benefit from this windfall.

If you decided to …

[Read Post »]

Advice for our children (and ourselves)

by Nilus Mattive |

I had a great Father’s Day weekend, spending time at the beach with both my dad and my daughter.

Having a chance to sit there, sandwiched between two generations, really gave me the opportunity to think about planning for the future and passing along some of the same lessons I’ve been taught over the years.

Probably the simplest and most effective thing I’ve ever learned is the need to keep things in balance.

It started when, as a young kid, my parents took me to the bank to open up a basic savings account.

[Read Post »]

Welcome to the ‘Next Generation’ Of Immunotherapy

by Frank Curzio |

I recently told you how the long-awaited revolution in the fight against cancer is here.

For the first time in more than 50 years, doctors have found a way to treat this dreadful disease — by using the capabilities of our own immune system.

This technology is called immunotherapy.

Some of the biggest pharmaceutical companies in the world are pouring tons of cash into this new treatment. And results show these companies are making amazing strides to prolong the lives of patients with some of the worst forms of cancer.

[Read Post »]